Estimating the efficacy of felzartamab to treat antibody-mediated rejection using the iBox prognostication system

Am J Transplant. 2024 Dec 12:S1600-6135(24)00752-4. doi: 10.1016/j.ajt.2024.12.004. Online ahead of print.
No abstract available

Keywords: Kidney transplantation; antibody-mediated; felzartamab; iBox; rejection.

Publication types

  • Letter